Research output per year
Research output per year
Fingerprint
Dive into the research topics where Center for Vaccine Research and Pandemic Preparedness is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
Research output
-
Accomplishments and challenges in developing improved influenza vaccines: An evaluation of three years of progress toward the milestones of the influenza vaccines research and development roadmap
The Influenza Vaccines R and D Roadmap Taskforce, 13 Aug 2025, In: Vaccine. 61, 127431.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
Addressing SARS-CoV-2 evolution: neutralization of emerging variants of concern by the AVX/COVID-12 ‘Patria’ vaccine based on HexaPro-S ancestral Wuhan spike or its updated BA.2.75.2 version
Carballo-Uicab, G., Mellado-Sánchez, G., González-González, E., Salinas-Trujano, J., Mendoza-Salazar, I., López-Olvera, K., Gómez-Castellano, K. M., Salazar, M. I., Torres-Flores, J. M., Chagoya-Cortés, H. E., Paz-De la Rosa, G., Mena, I., Rojas-Martínez, O., Lara-Puente, J. H., Peralta-Sánchez, G. J., Sarfati-Mizrahi, D., Torres-Flores, A., Sun, W., Krammer, F. & García-Sastre, A. & 5 others, , 2025, In: Frontiers in Immunology. 16, 1565934.Research output: Contribution to journal › Article › peer-review
-
An integrated approach for the accurate detection of HERV-K HML-2 transcription and protein synthesis
Gleason, C., Terry, S. N., Hernandez, M. M., Jacob, S., Fenyo, D., Johnson, J. R., Deikus, G., Francoeur, N., Hahn, A., Sebra, R., Zamarin, D., Molina, H., Simon, V. & Mulder, L. C. F., 27 Jan 2025, In: Nucleic Acids Research. 53, 2, gkaf011.Research output: Contribution to journal › Article › peer-review
Open Access -
Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens
El Sahly, H. M., Anderson, E. J., Jackson, L. A., Neuzil, K. M., Atmar, R. L., Bernstein, D. I., Chen, W. H., Creech, C. B., Frey, S. E., Goepfert, P., Meier, J., Phadke, V., Rouphael, N., Rupp, R., Stapleton, J. T., Spearman, P., Walter, E. B., Winokur, P. L., Yildirim, I. & Williams, T. L. & 10 others, , 15 Feb 2025, In: Vaccine. 47, 126689.Research output: Contribution to journal › Article › peer-review
-
A pan-orthohantavirus human lung xenograft mouse model and its utility for preclinical studies
Rissmann, M., Noack, D., Spliethof, T. M., Vaes, V. P., Stam, R., van Run, P., Clark, J. J., Verjans, G. M. G. M., Haagmans, B. L., Krammer, F., Koopmans, M. P. G., van den Brand, J. M. A. & Rockx, B., Jan 2025, In: PLoS Pathogens. 21, 1, e1012875.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
A review of currently licensed mucosal COVID-19 vaccines
Tscherne, A. & Krammer, F., 13 Aug 2025, In: Vaccine. 61, 127356.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
A single immunization with intranasal Newcastle disease virus (NDV)-based XBB.1.5 variant vaccine reduces disease and transmission in animals against matched-variant challenge
Slamanig, S., Lemus, N., Lai, T. Y., Singh, G., Mishra, M., Abdeljawad, A., Boza, M., Dolange, V., Singh, G., Lee, B., González-Domínguez, I., Schotsaert, M., Krammer, F., Palese, P. & Sun, W., 25 Jan 2025, In: Vaccine. 45, 126586.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
A Surrogate Enzyme-Linked Immunosorbent Assay to Select High-Titer Human Convalescent Plasma for Treating Immunocompromised Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern
Dolange, V., Slamanig, S., Abdeljawad, A., Lai, T. Y., Lemus, N., Singh, G., Carreño, J. M., Abbad, A., Srivastava, K., Simon, V., Sachithanandham, J., Pekosz, A., Sullivan, D., Krammer, F., Sun, W., Palese, P. & González-Domínguez, I., 15 Apr 2025, In: Journal of Infectious Diseases. 231, 4, p. e723-e733Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Clade 2.3.4.4b H5N1 neuraminidase has a long stalk, which is in contrast to most highly pathogenic H5N1 viruses circulating between 2002 and 2020
Hermann, E. & Krammer, F., Apr 2025, In: mBio. 16, 4Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Co-administration of seasonal quadrivalent influenza and COVID-19 vaccines leads to enhanced immune responses to influenza virus and reduced immune responses to SARS-CoV-2 in naive mice
Abbad, A., Yueh, J., Yellin, T., Singh, G., Carreño, J. M., Clark, J. J., Muramatsu, H., Tiwari, S., Bhavsar, D., Alzua, G. P., Pardi, N., Simon, V. & Krammer, F., 19 Mar 2025, In: Vaccine. 50, 126825.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Combination of recombinant neuraminidase with cHA-based inactivated split vaccines improves the breadth of cross-reactivity and protection against influenza viruses in mice
Puente-Massaguer, E., Vasilev, K. & Krammer, F., 13 Aug 2025, In: Vaccine. 61, 127388.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Editorial
Rasmussen, A. L., Hung, I. & Krammer, F., 25 Jan 2025, In: Vaccine. 45, 126642.Research output: Contribution to journal › Editorial
Press/Media
-
-
-
-
-
Human monoclonal antibodies targeting A35 protect from death against mpox
4/04/25
1 item of Media coverage
Press/Media
-
Data from Icahn School of Medicine at Mount Sinai Broaden Understanding of COVID-19 (Mucosal multivalent NDV-based vaccine provides cross-reactive immune responses against SARS-CoV-2 variants in animal models)
Chang, L., Krammer, F., Schotsaert, M., Palese, P. & Sun, W.
31/03/25
1 item of Media coverage
Press/Media
-
New COVID-19 Findings from Icahn School of Medicine at Mount Sinai Outlined (Xbb.1.5 Monovalent Vaccine Induces Lasting Cross-reactive Responses To Sars-cov-2 Variants Such As Hv.1 and Jn.1, As Well As Sars-cov-1, but Elicits Limited Xbb.1.5 ...)
Krammer, F., Mulder, L. & Simon, V.
28/03/25
1 item of Media coverage
Press/Media
-
Wistar Institute: Scientists Demonstrate Pre-clinical Proof of Concept for Next-Gen DNA Delivery Technology
21/03/25
1 item of Media coverage
Press/Media
-
Scientists Demonstrate Pre-clinical Proof of Concept for Next-Gen DNA Delivery Technology
21/03/25
77 items of Media coverage
Press/Media
-